Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes

Molecular and Cellular Biochemistry

Volumn 388, Issue 1-2, 2014, Pages 203-210

  Jayashree, B ^b   Bibin, Y S ^a   Prabhu, D ^a   Shanthirani, C S ^a   Gokulakrishnan, K ^a   Lakshmi, B S ^b   Mohan, V ^a   Balasubramanyam, M ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b ANNA UNIVERSITY   (India)

Author keywords

Gut permeability; LPS; Proinflammation; Type 2 diabetes; Zonulin

Indexed keywords

BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; ENDOTOXEMIA; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84893839605     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1911-4     Document Type: Article

References (38)

1. Pradhan JE, Manson N, Rifai JE et al (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334
2. Vozarova C, Weyer RS, Lindsay RE et al (2002) High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:455-460
3. Devaraj S, Dasu MR, Jialal I (2010) Diabetes is a proinflammatory state: a translational perspective. Endocrinol Metab 5:19-28
4. Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98-107
5. Hotamisligil GS (2001) Inflammation and metabolic disorders. Nature 444:860-867 (Pubitemid 46024993)
6. Gokulakrishnan K, Mohanavalli KT, Monickaraj F et al (2009) Subclinical inflammation/oxidation as revealed by altered gene expression profiles in subjects with impaired glucose tolerance and type 2 diabetes patients. Mol Cell Biochem 324:173-181
7. Balasubramanyam M, Aravind S, Gokulakrishnan K et al (2011) Impaired miR-146a expression links subclinical inflammation and insulin resistance in type 2 diabetes. Mol Cell Biochem 351:197-205
8. Cani PD, Bibiloni R, Knauf C et al (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470-1481
9. Creely SJ, McTernan PG, Kusminski CM (2007) Lipopolysaccharide activates an innateimmune system response in humanadipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292:E740-E747 (Pubitemid 46411051)
10. Sapone A, de Magistris L, Pietzak M et al (2006) Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 55:1443-1449 (Pubitemid 44195385)
11. Pradeepa R, Deepa R, Mohan V (2002) Epidemiology of diabetes in India - current perspective and future projections. J Indian Med Assoc 100:144-147
12. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 15:539-553 (Pubitemid 28319935)
13. Wendel M, Paul R, Heller AR (2007) Lipoproteins in inflammation and sepsis II. Clinical aspects. Intensive Care Med 33:25-35 (Pubitemid 46115467)
14. Pajkrt D, Doran JE, Koster F et al (1996) Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med 184:1601-1608 (Pubitemid 26404453)
15. Birjmohun RS, van Leuven SI, Levels JH et al (2007) High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans. Arter Thromb Vasc Biol 27:1153-1158 (Pubitemid 46641971)
16. Joshi SR (2012) Type 2 diabetes in Asian Indians. Clin Lab Med 32:207-216
17. Pussinen PJ, Tuomisto K, Jousilahti P et al (2007) Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arter Thromb Vasc Biol 27:1433-1439 (Pubitemid 46809435)
18. Pussinen PJ, Havulinna AS, Lehto M et al (2011) Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 34:392-397
19. Feingold KR, Staprans I, Memon RA et al (1992) Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 33:1765-1776 (Pubitemid 23006653)
20. Lassenius MI, Pietiläinen KH, Kaartinen K, FinnDiane Study Group et al (2011) Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 34:1809-1815
21. Nymark M, Pussinen PJ, Tuomainen AM, FinnDiane Study Group et al (2009) Serum lipopolysaccharide activity is associated with the progression of kidney disease in Finnish patients with type 1 diabetes. Diabetes Care 32:1689-1693
22. Buhl M, Bosnjak E, Vendelbo MH et al (2013) Direct effects of locally administered lipopolysaccharide on glucose, lipid, and protein metabolism in the placebo-controlled, bilaterally infused human leg. J Clin Endocrinol Metab 98:2090-2099
23. Erridge C, Attina T, Spickett CM et al (2007) A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86:1286-1292 (Pubitemid 350126229)
24. Cani PD, Amar J, Iglesias MA et al (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761-1772 (Pubitemid 47025442)
25. Sun L, Yu Z, Ye X et al (2010) A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33:1925-1932
26. Lira FS, Rosa JC, Pimentel GD et al (2010) Endotoxin levels correlate positively with a sedentary lifestyle and negatively with highly trained subjects. Lipids Health Dis 9:82
27. Oliveira Alexandre G, Bruno M et al (2011) Physical Exercise reduces circulating lipopolysaccharide and TLR4 activation and improves insulin signaling in tissues of DIO rats. Diabetes 60:784-796
28. Trøseid M, Nestvold TK, Rudi K et al (2013) Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery. Diabetes Care 36(11):3627-3632
29. Wang W, Uzzau S, Goldblum SE et al (2001) Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci 113:4425-4440
30. Watts T, Berti I, Sapone A et al (2005) Role of intestinal tight junction modulator zonulin in the pathogenesis of type 1 diabetes in BB diabetic prone rats. Proc Natl Acad Sci USA 102:2916-2921 (Pubitemid 40299891)
31. Moreno-Navarrete JM, Sabater M, Ortega F et al (2012) Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One 7:e37160
32. Backhed F, Ley RE, Sonnenburg JL et al (2005) Host-bacterial mutualism in the human intestine. Science 307:1915-1920 (Pubitemid 40404694)
33. de La Serre CB, Ellis CL, Lee J et al (2010) Propensity to high-fat diet- induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299:G440-G448
34. Larsen N et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5:e9085
35. Qin J, Li Y, Cai Z et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55-60
36. Manco M, Putignani L, Bottazzo GF (2010) Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 31:817-844
37. Amar J, Chabo C, Waget A et al (2011) Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 3:559-572
38. Fei N, Zhao L (2013) An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J 7:880-884